Navigation Links
Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
Date:1/30/2008

gory. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam Cold Remedy RapidMelts(TM); Zicam Allergy Relief; Zicam Cold Remedy Swabs(TM); Zicam Extreme Congestion Relief; Zicam Sinus Relief; as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to http://www.Zicam.com. To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at http://www.matrixxinc.com. For additional information, contact William Hemelt, Chief Financial Officer, 602-385-8888, or Bill Barba, Treasurer, at 602-385-8881. Matrixx is located at 4742 N. 24th Street, Suite 455, Phoenix, Arizona 85016.

Matrixx Initiatives, Inc. Forward-Looking Statement Disclaimer:

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "plan," "anticipate," and other similar statements of expectation identify forward-looking statements and include statements regarding: (i) our net sales and net income expectations for the fiscal year ending March
'/>"/>

SOURCE Matrixx Initiatives, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
2. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
3. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
5. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
6. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
7. Encision Reports Third Fiscal Quarter Results
8. Zimmer Reports Fourth Quarter and 2007 Financial Results
9. Amylin Pharmaceuticals Reports 2007 Financial Results
10. Cystic Fibrosis Foundation reports upward trend for key health outcomes
11. NBTY Reports First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced ... joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain ... evolving in the consumer goods industry, it can be difficult for companies to ...
(Date:9/4/2015)... ... September 04, 2015 , ... San ... available at CitiDent. CEREC is a newer method for creating restorations through innovative ... patients by eliminating the need for multiple appointments, CEREC produces restorations with total ...
(Date:9/4/2015)... Pass, OR (PRWEB) , ... September 04, 2015 ... ... that markets a line of personal humidifying medical devices, announced its only mission ... climate, explains Bio-Logic Aqua® Research Founder Sharon Kleyne, body water evaporation is becoming ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... development of its first neighborhood created specifically for adults with intellectual, developmental and ... Phoenix Metro area and feature 30 cottage or “pocket” homes. In this community, ...
(Date:9/4/2015)... ... ... and Overseer at The House of Yahweh, has written an open letter to Pope Francis ... United States. , Yisrayl lays out what he says is the true meaning of the ... provides the meaning of his own name and describes what bible prophecy says about his ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... have banned the sale of turbot after they detected ... of Beijing’s fish markets, reports the Chinese media. The ... in 1992. ,Due to low resistance to ... sometime leave harmful, carcinogenic residues in their flesh. ...
... continues to spiral with 4.3 million new infections //reported in ... the cases, states a new UNAIDS report. ,The UNAIDS/WHO ... globally 39.5 million people are living with HIV. Of these, ... who became newly infected in the past year. ...
... of onions, garlic and other alliums have a much ... who avoid the pungent herbs, new research shows. ... cancer studies to look at the relationship between onion ... including the mouth, larynx, esophagus, colon, breast, ovary, and ...
... nearly three fourth of hospitals in Canada may not be ... therapy to prostate cancer patients. ,As a reaction ... heavily on so-called benchmarks and targets set to achieve healthcare ... in the air. To achieve the targets, it is important ...
... Ravi Shankar and Bishop Lawrence Pius Dorai Raj//, have ... preventive care for a disease that has hit five ... much-needed prophetic voice to the stigma and discrimination related ... care for HIV infected people, providing them counselling as ...
... advanced new microscopy techniques in concert with sophisticated ... for the first time created three-dimensional, time-lapse movies ... tumor tissues. In recorded experiments, immune cells called ... tissues, making direct contact with tumor cells, and ...
Cached Medicine News:Health News:More then Four Million New HIV Infections in 2006: UNAIDS 2Health News:Onions, Garlic may Reduce the Risk of Cancer 2Health News:Spiritual Leaders Join Together to Fight Against HIV/AIDS in India 2Health News:Innovative Movies Show Real-Time Immune-Cell Activity within Tumors 2Health News:Innovative Movies Show Real-Time Immune-Cell Activity within Tumors 3
(Date:9/4/2015)... , Sept. 4, 2015  Allergan plc (NYSE: AGN ... Brent Saunders , CEO and President of Allergan, will provide ... Morgan Stanley Global Healthcare Conference 2015 in New ... The presentation will take place on ... the Grand Hyatt New York, 109 East 42nd Street, ...
(Date:9/4/2015)... 2015  IGI Laboratories, Inc. (NYSE MKT: IG), a ... pharmaceutical company, today announced it has submitted its seventh ... and Drug Administration (FDA) of 2015, which brings the ... the FDA to twenty-nine. Jason Grenfell-Gardner ... believe our current pipeline of twenty-nine submissions, exclusive of ...
(Date:9/4/2015)... 2015 Research and ... of the "Veterinary Pharmaceutical Submissions in the ... conference to their offering. This practical ... the constituent parts of the application for marketing ... a marketing authorisation is sought in the European ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2
... Phase III Results -, LAUSANNE, Switzerland, ... independent biopharmaceutical development specialist,focusing on serious medical ... 9th International Symposium on GnRH in Berlin, ... with its new 6-month formulation of,Decapeptyl(R)/Trelstar(R) (triptorelin), ...
... Phosphagenics,Limited ("Phosphagenics") (ASX: POH; AIM: PSG; OTCQX: PPGNY) ... phase 2 human clinical,trial to establish the efficacy ... syndrome is advancing at three sites in Adelaide,Australia., ... participants, the,double-blind phase 2 trial, which is fully ...
Cached Medicine Technology:Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer 2Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 2Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 4
... Craftsmanship have produced the finest ... Ocutek now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: